In vitro adherence of lymphocytes to dermal endothelium under shear stress: Implications in pathobiology and steroid therapy of acute cutaneous GVHD

Blood

Volumn 101, Issue 2, 2003, Pages 771-778

  Sackstein, Robert ^a   Messina, Jane L ^a   Elfenbein, Gerald J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; PACLITAXEL; STEROID; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM; FEMALE; FROZEN SECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; RASH; SHEAR STRESS; SKIN BIOPSY; SKIN CELL; SKIN GRAFT; STEROID THERAPY;

EID: 0037438382     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1452     Document Type: Article

References (53)

1. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol. 2001;29:259-277.
2. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825-828.
3. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood. 1990;76:1464-1472.
4. Spitzer TR, Sackstein R. Graft-vs-host disease - has any progress been made in the past decade? In: Bolwell B, ed. Current Controversies in Bone Marrow Transplantation. Totowa, NJ: Humana Press; 2000:229-248.
5. Woodruff JM, Hansen JA, Good RA, Santos GW, Slavin RE. The pathology of the graft-versus-host reaction (GVHR) in adults receiving bone marrow transplants. Transplant Proc. 1976;8:675-684.
6. Thomas JA, Wakeling WF, Imrie SF, Sloane JP, Powles RL, Lawler SD. Chimerism in skin of bone marrow transplant recipients. Transplantation. 1984;38:475-478.
7. Sviland L, Pearson ADJ, Green MA, et al. Immunopathology of early graft-versus-host disease - a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients. Transplantation. 1991;52:1029-1036.
8. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
9. Chin YH, Sackstein R, Cai JP. Lymphocytehoming receptors and preferential migration pathways. Proc Soc Exp Biol Med. 1991;196:374-380.
10. Sackstein R, Falanga V, Streilein JW, Chin YH. Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction. J Invest Dermatol. 1988;91:423-428.
11. Chin YH, Falanga V, Streilein JW, Sackstein R. Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction. J Invest Dermatol. 1989;93:82S-87S.
12. Jalkanen S, Steere AC, Fox RI, Butcher EC. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science. 1986;233:556-558.
13. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med. 1999:341:1817-1828.
14. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood. 1987;70:1382-1388.
15. Przepiorka D, Nath R, Iippoliti C, et al. A phase 1-11 study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma. Leuk Lymphoma. 1995;17:427-433.
16. Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood. 1994;84:2036-2043.
17. Blume KG, Forman SJ, O'Donnell MR, et al. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood. 1987;69:1015-1020.
18. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med. 1986;314:729-735.
19. Shepherd JD, Shore TB, Reece DE, et al. Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease. Bone Marrow Transplant. 1988;3:553-558.
20. Crilley P, Goldstein LJ. Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;15:361-365.
21. Elfenbein GJ, Janssen WE, Perkins JB. Relative contributions of marrow microenvironment, growth factors, and stem cells to hematopoiesis in vivo in man. Ann N Y Acad Sci. 1995;770:315-338.
22. Antman K, Ayash L, Elias A, et al. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol. 1992;10:102-110.
23. Elfenbein GJ, Perkins JB, Janssen WE, Partyka JS, Fields KK. Recovery of hematopoiesis after high dose therapy and autologous peripheral blood stem cell transplantation is clearly dependent upon the mobilizing regimen and the transplant regimen [abstract]. Blood. 1996;88:407a.
24. Lerner KG, Kao GF, Storb R, Buckner CD, Thomas ED. Histopathology of graft-versus-host reaction (GvHR) in human recipients of marrow from HLA-matched sibling donors. Transplant Proc. 1974;6:367-371.
25. Horn TD, Bauer DJ, Vogelsang GB, Hess AD. Reappraisal of histologic features of acute cutaneous graft-versus-host reaction based on an allogeneic rodent model. J Invest Dermatol. 1994;103:206-210.
26. Glass LF, Fotopoulos T, Messina JL. A generalized cutaneous reaction induced by granulocyte colony-stimulating factor. J Am Acad Dermatol. 1996;34:455-459.
27. Sackstein R, Meng L, Xu XM, Chin YH. Evidence of post-transcriptional regulation of L-selectin gene expression in rat lymphoid cells. Immunology. 1995;85:198-204.
28. Sackstein R, Fu L, Allen KL. A hematopoietic cell L-selectin ligand exhibits sulfation-independent binding activity. Blood. 1997;89:2773-2781.
29. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol. 2001;153:1277-1286.
30. Stamper HB, Woodruff JJ. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J Exp Med. 1976;144:828-833.
31. Warnock RA, Askari S, Butcher EC, von Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med. 1998;187:205-216.
32. Von Andrian UH, Mackay CR. T-cell function and migration. N Engl J Med. 2000;343:1020-1034.
33. Chin YH, Falanga V, Taylor JR, Cai JP, Bax J. Adherence of human helper/memory T-cell subsets to psoriatic dermal endothelium. J Invest Dermatol. 1990;94:413-417.
34. Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ. The human peripheral lymph node vascular addressin: an inducible endothelial antigen involved in lymphocyte homing. Am J Pathol. 1993;143:1688-1698.
35. Wakita H, Takigawa M. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol. 1994;130:457-463.
36. Norton J, Sloane JP, Al-Saffar N, Haskard DO. Vessel associated adhesion molecules in normal skin and acute graft-versus-host disease. J Clin Pathol. 1991;44:586-591.
37. Weninger W, Ulfman LH, Cheng G, et al. Specialized contributions by α(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity. 2000;12:665-676.
38. Masuyama J, Minato N, Kano S. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture: T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. J Clin Invest. 1986;77:1596-1605.
39. Colson YL, Markus BH, Zeevi A, Duquesnoy RJ. Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognition. J Immunol. 1990;144:2975-2984.
40. Vogelsang GB, Hess AD, Berkman AW, et al. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med. 1985;313:645-650.
41. Sviland L, Dickinson AM, Carey PJ, Pearson ADJ, Proctor SJ. An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1990;5:105-109.
42. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticold receptor regulates leukocyte adhesion to enclothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1992;89:991-995.
43. Vogelsang GB, Jones RJ, Hess AD, Geller R, Schucter L, Santos GW. Induction of autologous graft-versus-host disease. Transplant Proc. 1989;21:2997-2998.
44. Baron F, Gothot A, Salmon JP, et al. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. Br J Haematol. 2000;111:745-753.
45. Lampert IA, Janossy G, Suitters AJ, et al. Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol. 1982;50:123-131.
46. Kaye VN, Neumann PM, Kersey J, et al. Identity of immune cells in graft-versus-host disease of the skin. Am J Pathol. 1984;116:436-440.
47. Takata M, Imai T, Hirone T. Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation. J Clin Pathol. 1993;46:801-805.
48. Diamond DJ, Chang KL, Jenkins KA, Forman SJ. Immunohistochemical analysis of T cell phenotypes in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation. 1995;59:1436-1444.
49. Rhoades JL, Cibull ML, Thompson JS, et al. Role of natural killer cells in the pathogenesis of human acute graft-versus-host disease. Transplantation. 1993;56:113-120.
50. Ferrara JLM, Guillen FJ, van Dijken PJ, Marion A, Murphy GF, Burakoff SJ. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation. 1989;47:50-54.
51. Gaschet J, Treviño MA, Cherel M, et al. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease. Blood. 1996;87:2345-2353.
52. Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol. 1983;80:125-175.
53. Martin PJ, Hansen JA, Buckner CD, et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood. 1985;66:664-672.